An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations.
Horizontal gene transfer (HGT)
Immunization
SARS-CoV-2
Vaccination
mRNA-based Vaccine
Journal
International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
09
12
2022
revised:
09
02
2023
accepted:
21
02
2023
medline:
4
4
2023
pubmed:
4
3
2023
entrez:
3
3
2023
Statut:
ppublish
Résumé
The worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has urged scientists to present some novel vaccine platforms during this pandemic to provide a rather prolonged immunity against this respiratory viral infection. In spite of many campaigns formed against the administration of mRNA-based vaccines, those platforms were the most novel types, which helped us meet the global demand by developing protection against COVID-19 and reducing the development of severe forms of this respiratory viral infection. Some societies are worry about the COVID-19 mRNA vaccine administration and the potential risk of genetic integration of inoculated mRNA into the human genome. Although the efficacy and long-term safety of mRNA vaccines have not yet been fully clarified, obviously their application has switched the mortality and morbidity of the COVID-19 pandemic. This study describes the structural features and technologies used in producing of COVID-19 mRNA-based vaccines as the most influential factor in controlling this pandemic and a successful pattern for planning to produce other kind of genetic vaccines against infections or cancers.
Identifiants
pubmed: 36867924
pii: S1567-5769(23)00254-0
doi: 10.1016/j.intimp.2023.109934
pmc: PMC9968612
pii:
doi:
Substances chimiques
COVID-19 Vaccines
0
RNA, Messenger
0
mRNA Vaccines
0
Viral Vaccines
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
109934Informations de copyright
Copyright © 2023 Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
Mol Ther. 2019 Apr 10;27(4):757-772
pubmed: 30803823
Age Ageing. 2021 Feb 26;50(2):279-283
pubmed: 33320183
Biol Proced Online. 2020 Jul 23;22:16
pubmed: 32754004
J Infect Dis. 2022 Apr 1;225(7):1141-1150
pubmed: 34888672
N Engl J Med. 2021 Dec 2;385(23):2132-2139
pubmed: 34614329
Proc Natl Acad Sci U S A. 2021 May 25;118(21):
pubmed: 33958444
Breastfeed Med. 2021 Sep;16(9):702-709
pubmed: 34171971
ACS Infect Dis. 2019 Sep 13;5(9):1546-1558
pubmed: 31290323
Cell. 2020 Jul 9;182(1):73-84.e16
pubmed: 32425270
PLoS One. 2020 Aug 14;15(8):e0237691
pubmed: 32797067
Hum Vaccin Immunother. 2023 Dec 31;19(1):2153532
pubmed: 36629006
N Engl J Med. 2022 Mar 10;386(10):995-998
pubmed: 35081300
PLoS Pathog. 2020 Aug 21;16(8):e1008762
pubmed: 32822426
Ann Emerg Med. 2021 Jun;77(6):654-656
pubmed: 34030782
Nat Med. 2022 Jan;28(1):39-50
pubmed: 35064248
BMC Res Notes. 2021 Jan 6;14(1):10
pubmed: 33407800
Front Microbiol. 2022 Jun 27;13:948770
pubmed: 35832809
Cell Rep. 2021 Aug 17;36(7):109530
pubmed: 34380018
Virus Res. 2021 Sep;302:198466
pubmed: 34087261
Gene Ther. 2017 Mar;24(3):133-143
pubmed: 28094775
Biomed Pharmacother. 2021 Jun;138:111518
pubmed: 33774315
MMWR Morb Mortal Wkly Rep. 2022 Jul 01;71(26):859-868
pubmed: 35771731
Vaccine. 2017 Jan 5;35(2):361-368
pubmed: 27939014
J Genet Genomics. 2021 Feb 20;48(2):107-114
pubmed: 34006471
Int J Mol Sci. 2023 Jan 04;24(2):
pubmed: 36674422
Zhonghua Jie He He Hu Xi Za Zhi. 2020 Feb 15;43(0):E013
pubmed: 32061066
J Gen Virol. 2017 Feb;98(2):131-133
pubmed: 28284245
NPJ Vaccines. 2017 Oct 19;2:29
pubmed: 29263884
Microb Pathog. 2021 Mar;152:104554
pubmed: 33157216
Rheumatology (Oxford). 2022 Dec 23;62(1):65-76
pubmed: 35713499
Int J Biol Sci. 2021 Apr 10;17(6):1446-1460
pubmed: 33907508
Mol Microbiol. 2014 Oct;94(2):254-71
pubmed: 25080967
J Virol. 2010 Nov;84(22):11876-87
pubmed: 20810725
RNA Biol. 2012 Nov;9(11):1319-30
pubmed: 23064118
Nat Rev Immunol. 2013 Jun;13(6):453-60
pubmed: 23681101
Eur J Clin Invest. 2021 Nov;51(11):e13678
pubmed: 34529274
Cell. 2020 May 28;181(5):1004-1015.e15
pubmed: 32375025
Front Immunol. 2020 Oct 14;11:585354
pubmed: 33163000
Nat Med. 2021 Feb;27(2):279-288
pubmed: 33335322
J Control Release. 2021 May 10;333:511-520
pubmed: 33798667
BMJ Case Rep. 2021 Jul 30;14(7):
pubmed: 34330729
Front Chem. 2020 Oct 23;8:589959
pubmed: 33195094
Proc Natl Acad Sci U S A. 2019 Nov 26;116(48):24075-24083
pubmed: 31712433
Trop Med Health. 2020 Nov 23;48(1):91
pubmed: 33292755
Front Mol Biosci. 2021 Apr 15;8:635337
pubmed: 33937326
Br J Haematol. 2021 Aug;194(3):547-549
pubmed: 33934330
Lancet. 1998 Mar 21;351(9106):907-8; author reply 908-9
pubmed: 9525396
Lancet. 2020 Aug 15;396(10249):479-488
pubmed: 32702299
Database (Oxford). 2021 May 18;2021:
pubmed: 34003248
Ther Deliv. 2016;7(5):319-34
pubmed: 27075952
Cell Mol Life Sci. 2019 Jan;76(2):301-328
pubmed: 30334070
J Pharm Sci. 2021 Mar;110(3):997-1001
pubmed: 33321139
Biol Proced Online. 2020 Apr 21;22:8
pubmed: 32336957
N Engl J Med. 2021 May 13;384(19):1866-1868
pubmed: 33761203
N Engl J Med. 2021 Dec 16;385(25):e92
pubmed: 34758250
Transl Psychiatry. 2022 Feb 1;12(1):49
pubmed: 35105851
Nanomedicine. 2014 May;10(4):775-82
pubmed: 24361386
J Control Release. 2021 Jul 10;335:237-246
pubmed: 34019945
N Engl J Med. 2021 Feb 4;384(5):403-416
pubmed: 33378609
Nat Rev Immunol. 2021 Apr;21(4):200-201
pubmed: 33658707
Science. 2020 Sep 25;369(6511):1586-1592
pubmed: 32694201
Int J Pharm. 2021 May 15;601:120586
pubmed: 33839230
Mol Ther. 2017 Jul 5;25(7):1467-1475
pubmed: 28412170
Curr Top Microbiol Immunol. 2022;440:167-186
pubmed: 35906319
Curr Opin Immunol. 2021 Aug;71:111-116
pubmed: 34330017
Mol Ther. 2015 Sep;23(9):1456-64
pubmed: 26050989
Lancet. 1998 Mar 21;351(9106):907; author reply 908-9
pubmed: 9525394
Nat Rev Drug Discov. 2018 Apr;17(4):261-279
pubmed: 29326426
Lancet. 2020 Jun 13;395(10240):1845-1854
pubmed: 32450106
Nat Nanotechnol. 2020 Aug;15(8):646-655
pubmed: 32669664
Eur J Pharm Biopharm. 2009 Mar;71(3):484-9
pubmed: 18948192
Med Sci Monit. 2020 May 05;26:e924700
pubmed: 32366816
J Hepatol. 2021 Jul;75(1):222-224
pubmed: 33862041
Lancet Respir Med. 2022 Feb;10(2):e17
pubmed: 34929158
Blood. 2006 Dec 15;108(13):4009-17
pubmed: 16940422
MMWR Morb Mortal Wkly Rep. 2022 Nov 11;71(45):1436-1441
pubmed: 36355612
Asian J Pharm Sci. 2022 Jul;17(4):491-522
pubmed: 36105317
Annu Rev Genomics Hum Genet. 2021 Aug 31;22:199-218
pubmed: 33792357
N Engl J Med. 2022 Jan 6;386(1):35-46
pubmed: 34752019
Future Virol. 2021 Nov;:
pubmed: 34887937
Lancet Infect Dis. 2023 Jan;23(1):2-3
pubmed: 36152670
Elife. 2021 Feb 05;10:
pubmed: 33543709
Expert Rev Vaccines. 2021 Aug;20(8):1013-1025
pubmed: 34180347
Headache. 2021 Mar;61(3):409-411
pubmed: 33543775
Nat Rev Immunol. 2021 Aug;21(8):475-484
pubmed: 34211186
Pharmacol Rev. 2022 Jan;74(1):313-339
pubmed: 35101964
Immunology. 2022 Apr;165(4):386-401
pubmed: 34957554
Int J Environ Res Public Health. 2023 Jan 16;20(2):
pubmed: 36674401
J Nanobiotechnology. 2022 Jun 14;20(1):276
pubmed: 35701851
Nucleic Acids Res. 2021 Oct 11;49(18):10604-10617
pubmed: 34520542
Science. 2022 Mar 11;375(6585):1127-1132
pubmed: 35271316
Front Immunol. 2018 Sep 19;9:1963
pubmed: 30283434
Nature. 2021 Apr;592(7853):283-289
pubmed: 33524990
Infect Dis Rep. 2021 Jul 31;13(3):685-699
pubmed: 34449637
Wien Klin Wochenschr. 2021 Sep;133(17-18):931-941
pubmed: 34378087
Methods Mol Biol. 2020;2086:87-117
pubmed: 31707670
Sci Adv. 2020 Jun 24;6(26):eaaz6893
pubmed: 32637598
Pharmaceutics. 2020 Jan 28;12(2):
pubmed: 32013049
Lancet Microbe. 2021 Oct;2(10):e494
pubmed: 34458880
Eur J Pharmacol. 2021 Mar 15;895:173890
pubmed: 33482181
Clin Rheumatol. 2021 Feb;40(2):797-798
pubmed: 33426632
Lancet. 1998 Mar 21;351(9106):905-6; author reply 908-9
pubmed: 9525391
Biochem Biophys Res Commun. 1997 Nov 26;240(3):793-7
pubmed: 9398647
J Hepatol. 2021 Nov;75(5):1249-1250
pubmed: 34171435
Infect Control Hosp Epidemiol. 2021 Mar;42(3):375-376
pubmed: 32408917
N Engl J Med. 2020 Dec 31;383(27):2603-2615
pubmed: 33301246
Vaccines (Basel). 2021 Feb 12;9(2):
pubmed: 33673048
Med Devices Sens. 2021 Feb;4(1):e10163
pubmed: 33615150
BMC Genomics. 2020 May 11;21(1):352
pubmed: 32393172
Lancet. 1998 Mar 21;351(9106):906-7; author reply 908-9
pubmed: 9525393
Cell. 2020 May 14;181(4):894-904.e9
pubmed: 32275855
Curr Opin Virol. 2017 Aug;25:16-22
pubmed: 28672159
Front Microbiol. 2020 Aug 13;11:1818
pubmed: 32903349
Annu Rev Med. 2022 Jan 27;73:17-39
pubmed: 34669432
Immunity. 2020 Apr 14;52(4):583-589
pubmed: 32259480
JAMA. 2022 Feb 15;327(7):617-618
pubmed: 35029659
Expert Rev Vaccines. 2021 Dec;20(12):1619-1628
pubmed: 34592123